Search the Newsreel

Here's How Much $1000 Invested In BWX Technologies 10 Years Ago Would Be Worth Today

An investment of $1000 in BWX Technologies (NYSE: BWXT) 10 years ago would be worth $4,453.59 today, demonstrating an annualized return of 15.91%. This performance has outperformed the market by 2.37% annually. The article highlights the significant impact of compounded returns on investment growth …

BWX Technologies (NYSE:BWXT) CEO Rex Geveden Sells 10,000 Shares of Stock

BWX Technologies CEO Rex Geveden sold 10,000 shares of the company's stock for $1.725 million under a pre-arranged trading plan, reducing his holdings to 192,491 shares. The sale followed strong quarterly results, with adjusted EPS and revenue exceeding expectations, and the company reaffirmed its …

BWX Technologies (BWXT) CEO Geveden sells 10,000 shares under Rule 10b5-1 plan

BWX Technologies (BWXT) CEO Rex D. Geveden sold a total of 10,000 shares of common stock on August 12, 2026, at weighted average prices between $170.65 and $174.24 per share. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan that was adopted …

How Investors May Respond To BWX Technologies (BWXT) Raised 2026 Outlook And Nuclear Enrichment Push

BWX Technologies (BWXT) recently reported strong Q2 and H1 2026 results, raising its full-year 2026 revenue outlook to $3.80 billion and declaring a $0.27 quarterly dividend. The company is also accelerating its uranium centrifuge technology work with the National Nuclear Security Administration to support …

BWX Technologies (NYSE: BWXT) insider plans sale of 10,000 shares valued at $1.73M

An insider at BWX Technologies, Rex D. Geveden, plans to sell 10,000 shares of common stock valued at $1.73 million on or after August 12, 2026. These shares were acquired through RSU/PSU equity compensation on February 27, 2023. This planned sale follows a prior …

31,104 Shares in BWX Technologies, Inc. $BWXT Acquired by Insight Wealth Strategies LLC

Insight Wealth Strategies LLC recently acquired 31,104 shares of BWX Technologies, Inc. (BWXT) valued at approximately $5.95 million. This move is part of broader institutional interest, with hedge funds and institutional investors collectively owning 94.39% of the company. BWXT reported strong quarterly earnings, surpassing …

Tema ETFs LLC Acquires 25,368 Shares of BWX Technologies, Inc. $BWXT

Tema ETFs LLC significantly increased its stake in BWX Technologies (NYSE:BWXT) by 45.5% in the second quarter, adding 25,368 shares to reach a total of 81,179 shares valued at approximately $15.8 million. Institutional investors now hold 94.39% of BWXT's stock, reflecting strong institutional confidence. …

Renaissance Technologies LLC Buys New Stake in BWX Technologies, Inc. $BWXT

Renaissance Technologies LLC has acquired a new stake of 11,600 shares in BWX Technologies, Inc. (NYSE:BWXT) valued at approximately $2.37 million during the first quarter. BWX Technologies reported strong financial results with quarterly EPS of $1.07, surpassing estimates, and revenue up 18% year-over-year. Analysts …

Can BWX Technologies (BWXT) Still Look Like A Bargain After Raised Revenue Guidance?

The Technical Signals Behind (BWXT) That Institutions Follow

This article provides a technical analysis of Bwx Technologies Inc. (NASDAQ: BWXT), highlighting neutral near and mid-term readings but a positive long-term bias. It outlines three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles. The analysis also includes multi-timeframe …

BWX Technologies, Inc. (NYSE:BWXT) Given Average Recommendation of "Moderate Buy" by Brokerages

BWX Technologies, Inc. (BWXT) has received an average "Moderate Buy" rating from fifteen brokerages, with an average 12-month price target of $228.20. The company recently exceeded quarterly earnings expectations with an EPS of $1.07 and revenue of $901.62 million, and guided for fiscal 2026 …

BWX Technologies (NYSE:BWXT) Downgraded by Wall Street Zen to Hold

Wall Street Zen has downgraded BWX Technologies (NYSE:BWXT) from "Buy" to "Hold" despite a broader analyst consensus of "Moderate Buy" with an average price target of $228.20. The company recently reported strong quarterly earnings, beating EPS estimates and seeing an 18% year-over-year revenue increase, …

Pacer Advisors Inc. Sells 1,998,424 Shares of BWX Technologies, Inc. $BWXT

Pacer Advisors Inc. significantly reduced its stake in BWX Technologies, selling 1,998,424 shares and retaining 30,477 shares. Despite this, other institutional investors have recently increased their holdings, and institutions still own 94.39% of the company. BWX Technologies reported strong Q1 earnings, exceeding analyst expectations, …

BWX Technologies (NYSE: BWXT) lifts Q2 sales 18% as backlog hits $8,398.1M

BWX Technologies reported an 18% year-over-year increase in Q2 2026 revenue to $901.6 million and a 21.8% rise in year-to-date revenue to $1.76 billion, driven by strong growth in Commercial Operations and recent acquisitions. The company's backlog reached $8,398.1 million, with 55% expected to …

BWX Technologies (BWXT) Stock Price Lags Backlog Surge and Premium P E

BWX Technologies (BWXT) saw its stock price barely move despite a strong Q2 earnings report, including an 18% revenue increase, a 14% rise in net income, and a 40% jump in backlog to $8.4 billion. The article explores the bull case, highlighting the company's …

Janus Henderson Group PLC Sells 77,120 Shares of BWX Technologies, Inc. $BWXT

Janus Henderson Group PLC reduced its stake in BWX Technologies (NYSE:BWXT) by 52.5% in the first quarter, selling 77,120 shares but still retaining 69,794 shares valued at $14.3 million. Despite this sale, institutional investors collectively own 94.39% of the company. BWX Technologies reported strong …

BWX Technologies Stock (BWXT) Opinions on Earnings Growth and Nuclear Demand

Should BWX Technologies’ Guidance Hike and Medical Exit Reshape BWXT’s Nuclear‑Focused Investment Case?

BWX Technologies, Inc. reported past Q2 2026 results with sales of US$901.63 million and net income of US$89.01 million, raised full‑year 2026 revenue guidance to about US$3.80 billion, and its board declared a US$0.27 per‑share quarterly dividend payable on September 4, 2026. At the …

BWXT Q2 Earnings Call Centers on Higher Outlook and Nuclear Focus

BWX Technologies, Inc. (BWXT) reported strong Q2 2026 earnings, surpassing analyst estimates for both earnings per share and revenue. The company raised its full-year outlook, emphasizing a sharpened strategic focus on core nuclear markets, expanding nuclear manufacturing capacity, and benefits from the sale of …

BWX Technologies (BWXT) Sells Medical Business And Signs New Thorium Fuel Deal

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. BWX Technologies (NYSE:BWXT) has agreed to sell its medical business to Nordic Capital, while keeping a minority interest and technical involvement. The company …

BWX TECHNOLOGIES INC : BNP PARIBAS CUTS TARGET PRICE TO $190 FROM $230

BNP Paribas has cut its target price for BWX Technologies Inc. (BWXT.N) from $230 to $190. This financial adjustment was reported by Reuters on August 4, 2026.

The Manufacturers Life Insurance Company Has $9.72 Million Position in BWX Technologies, Inc. $BWXT

The Manufacturers Life Insurance Company reduced its stake in BWX Technologies (NYSE:BWXT) by 28.5% in Q1, selling 18,987 shares but retaining a $9.72 million position. Despite this, institutional ownership remains high at 94.39%. BWXT exceeded Q2 earnings expectations, reporting $1.07 adjusted EPS, and modestly …

Segall Bryant & Hamill LLC Invests $4.46 Million in BWX Technologies, Inc. $BWXT

Segall Bryant & Hamill LLC has invested $4.46 million in BWX Technologies, Inc. by acquiring 22,764 shares. This comes as institutional investors now own 94.39% of BWXT's outstanding stock. BWX Technologies recently reported strong Q2 earnings, beating analyst estimates and raising fiscal 2026 EPS …

BWXT targets $4.70-$4.80 EPS and raises 2026 free cash flow outlook to $345M-$360M amid medical sale

Earnings Call Insights: BWX Technologies (BWXT) Q2 2026 MANAGEMENT VIEW * "We delivered another strong quarter, characterized by excellent execution across the company and continued momentum in commercial nuclear." (President, CEO & Director Rex Geveden) * "We announced the sale of our medical business …

BWX Technologies Inc (BWXT) carries 12-week weakness into results week

The Aug. 3 report matters because the nuclear-components maker is approaching earnings with medium-term performance under pressure and no active trend confirmation.

BWX Technologies Inc (BWXT) (Q2 2026) Earnings Call Highlights: Record Backlog and Strategic ...

This article first appeared on GuruFocus. Revenue: $902 million in Q2 2026, up 18% year-over-year, including 9% organic growth. Adjusted EBITDA: $156 million, up 7% year-over-year. Adjusted EPS: $1.07, up 5% year-over-year. Free Cash Flow: $115 million in Q2 2026; full-year guidance raised to …

BWX Technologies, Inc. Reports Increase In Q2 Income

(RTTNews) - BWX Technologies, Inc. (BWXT) reported earnings for its second quarter that Increases, from last year The company's earnings totaled $89.01 million, or $0.97 per share. This compares with $78.39 million, or $0.85 per share, last year. Excluding items, BWX Technologies, Inc. reported …

Nordic Capital agreed to acquire Medical business of BWX Technologies, Inc. from BWX Technologies, Inc..

Nordic Capital has agreed to acquire the Medical business of BWX Technologies, Inc. (NYSE:BWXT) in a transaction expected to close by the end of 2026, pending regulatory approvals. BWX Technologies will retain a minority ownership stake and continue to provide specialized isotope and radiochemical …

BWXT to sell medical business for $800M

BWX Technologies (BWXT) has announced an agreement to sell its medical business, including BWXT Medical and Kinectrics’ stable medical isotopes business, to Nordic Capital for up to $800 million. The transaction is expected to close by year-end and will allow BWXT to focus on …

BWX Technologies (NYSE:BWXT) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

BWX’s (NYSE:BWXT) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

BWX's (NYSE:BWXT) Q2 CY2026 Earnings Results: Revenue In Line With Expectations Aerospace and defense company BWX (NYSE:BWXT) met Wall Street's revenue expectations in Q2 CY2026, with sales up 18% year on year to $901.6 million. Its non-GAAP profit of $1.07 per share was 2.7% …

BWXT Selling Medical Business to Nordic Capital in Transaction Valued at up to $800 Million

BWXT will retain a minority ownership in the new company LYNCHBURG, Va., Aug. 3, 2026 /PRNewswire/ -- BWX Technologies, Inc. (NYSE: BWXT) announced today it has entered into a definitive agreement to sell its medical business to Nordic Capital, an experienced healthcare investor with …

BWXT Keeps Minority Stake as Nordic Capital Buys Medical Unit

BWX Technologies, Inc. (BWXT) has agreed to sell its medical business, including BWXT Medical and Kinectrics' stable medical isotopes business, to Nordic Capital for up to $800 million. BWXT will retain a minority ownership stake in the divested business and continue providing specialized isotope …